Dennis Miller, R.Ph. is a retired chain store pharmacist. His book, The Shocking Truth About Pharmacy: A Pharmacist Reveals All the Disturbing Secrets, can be downloaded in its entirety at Amazon for 99 cents.
Too often, modern medicine presents itself as a neutral exchange of expertise when it can function, in practice, as a hierarchy that protects authority, habit, and prescription culture. When patients arrive with questions, studies, and doubts, the problem is not simply disagreement over evidence. It is often a struggle over who gets to define risk, who gets to set the terms of discussion, and who is expected to remain silent.
The Myth of Neutral Prescribing
Doctors are often portrayed as detached experts who calmly weigh evidence and recommend what is best. That image is flattering, but it can also be misleading. In many clinical settings, the recommendation to start, continue, or switch a drug is shaped not only by science, but by habit, time pressure, professional culture, reimbursement structures, and the broader pharmaceutical marketplace. The result is a medical conversation that can sound objective while quietly narrowing what counts as a reasonable question.
Benefits Get the Spotlight
One of the most persistent problems in medicine is the imbalance in how treatments are described. Benefits are often made vivid, immediate, and personal: this drug may lower your numbers, reduce your symptoms, improve your chances, protect your future. Risks, by contrast, are frequently delivered in a flattened monotone, buried in generalities, or framed as statistically remote. The patient hears promise in plain language and caution in fine print.
That asymmetry matters. It shapes consent before consent has even begun. A patient cannot make an informed choice if the upside is dramatized and the downside is treated as a technical footnote. If medicine wants to claim the moral authority of informed consent, it must stop marketing benefit and minimizing uncertainty.
When Patients Bring the Literature
Many patients have experienced the chill that enters the room when they bring a journal article to an appointment. The paper may question the safety of a drug, challenge the size of its benefit, or raise doubts about a procedure already recommended. What should happen next is straightforward: discussion, interpretation, humility, and a transparent review of the evidence. What often happens instead is dismissal.
The patient is told the article is not relevant, too old, too narrow, misread, or outweighed by “clinical experience.” Sometimes that is true. But too often the defensive reflex arrives before any real engagement with the paper itself. The issue is no longer the evidence. The issue is that the patient has crossed an invisible line by refusing the passive role medicine still too often expects.
This Is Also About Power
It is comforting to pretend these encounters are only about expertise. They are not. They are also about authority. Physicians are trained, licensed, and socialized to occupy the top position in the exam room. Patients who arrive prepared, skeptical, or unwilling to be steered can disrupt that order. A question about evidence can quickly be experienced as a challenge to status.
That is why some doctors seem far more irritated by a well-read patient than by an uninformed one. The irritation is not always caused by the content of the article. It stems from the fact that the patient is no longer acting like a subordinate. The patient is asserting interpretive agency in a system that still rewards deference.
Prescription Culture as a Business Model
In large parts of healthcare, prescribing is not incidental. It is central. Entire specialties and practice patterns are organized around medication management. That does not prove bad faith, but it does create structural incentives. When a profession routinely relies on pharmaceuticals as its primary instrument, criticism of pharmaceuticals can feel like criticism of the profession itself.
Under those conditions, a broad public skepticism toward drug culture is threatening. It threatens revenue streams, treatment routines, professional identity, and the assumption that more intervention is usually better than less. The doctor may sincerely believe a prescription is helpful, yet still be embedded in a system that reflexively favors medication over restraint.
The Emotional Cost of Admitting Harm
There is also a more personal problem. It is psychologically difficult for any conscientious physician to accept that a treatment meant to help may also injure. Medicine asks doctors to act decisively. It rewards confidence, not hesitation. But the real world of therapeutics is messy: side effects are common, long-term effects can emerge late, trial populations are selective, and benefits that look impressive in journals may be modest in ordinary life.
This is where cognitive dissonance enters. A physician may hold two clashing beliefs at once: I help people with these drugs, and these drugs can seriously harm people. The tension between those beliefs can produce humility, but it can also produce denial, minimization, or defensiveness. When a patient arrives with evidence of harm, the article is not just challenging a recommendation. It may be challenging the doctor’s self-concept as a healer.
Expertise Should Not Mean Immunity From Scrutiny
None of this means doctors know nothing or that patients know more. It means expertise is not a license to avoid challenge. True expertise should be able to explain itself, compare options honestly, acknowledge uncertainty, and tolerate scrutiny without treating skepticism as insubordination. A profession confident in its evidence would not need to flinch when patients read the literature.
The Paternalism That Lingers
Medicine speaks endlessly about patient-centered care, but old paternal habits remain. They show up in tone, in time pressure, in selective framing, and in the subtle message that a “good” patient is a compliant patient. Shared decision-making is often celebrated in theory and diluted in practice. Patients are invited to participate, but only within boundaries defined in advance by the clinician.
The most revealing moment comes when a patient declines the recommended path after reviewing evidence and considering alternatives. If the doctor responds with curiosity, that is collaboration. If the doctor responds with annoyance, ridicule, or pressure, that is paternalism with modern branding.
What Honest Risk Communication Would Look Like
Honest prescribing would sound different. It would include absolute benefit, not just relative benefit. It would name common side effects plainly and discuss serious but less common harms without theatrical reassurance. It would compare the drug with alternatives, including watchful waiting, lifestyle changes, dose reduction, or doing nothing for now. It would welcome questions instead of treating them as friction.
Patients Are Not Threats to the Profession
A patient who asks whether a drug is overstated, overprescribed, or insufficiently studied is not sabotaging medicine. That patient is doing what medicine claims to value: paying attention to evidence, weighing tradeoffs, and trying to avoid preventable harm. The profession should not fear that behavior. It should depend on it.
The Reform Begins With Humility
The deeper problem is not that doctors are human. Of course they are. The problem is that medicine too often denies the human pressures that distort judgment: status, routine, financial structure, professional pride, fear of error, and discomfort with ambiguity. Until those pressures are openly acknowledged, the language of objectivity will keep disguising power as pure expertise.
Patients do not need doctors to be infallible. They need them to be candid. They need physicians who can say: this drug may help, the evidence has limits, the risks are real, and your questions are legitimate. The future of ethical medicine will not be secured by preserving the doctor’s upper hand. It will be secured by replacing reflexive authority with transparency, intellectual honesty, and genuine shared decision-making.
Dennis Miller, R.Ph. is a retired chain store pharmacist. His book, The Shocking Truth About Pharmacy: A Pharmacist Reveals All the Disturbing Secrets, can be downloaded in its entirety at Amazon for 99 cents.
